Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27521770)

  • 1. Fertility counseling and preservation practices in youth with lupus and vasculitis undergoing gonadotoxic therapy.
    Nahata L; Sivaraman V; Quinn GP
    Fertil Steril; 2016 Nov; 106(6):1470-1474. PubMed ID: 27521770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
    Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
    Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.
    Harward LE; Mitchell K; Pieper C; Copland S; Criscione-Schreiber LG; Clowse ME
    Lupus; 2013 Jan; 22(1):81-6. PubMed ID: 23263867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility preservation in women with vasculitis: experiences from the FertiPROTEKT network.
    Henes JC; Henes M; von Wolff M; Schmalzing M; Kötter I; Lawrenz B
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S53-6. PubMed ID: 22512886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in paediatric nephrology: results of a physician survey.
    Miller SD; Li Y; Meyers KE; Caplan A; Miller VA; Ginsberg JP
    J Ren Care; 2014 Dec; 40(4):257-62. PubMed ID: 24980474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which female cancer patients fail to receive fertility counseling before treatment in the state of Georgia?
    Chin HB; Howards PP; Kramer MR; Mertens AC; Spencer JB
    Fertil Steril; 2016 Dec; 106(7):1763-1771.e1. PubMed ID: 27678034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can fertility counseling be implemented for every newly diagnosed pediatric patient facing gonadotoxic treatment?-A single-center experience.
    Barnbrock A; Salzmann-Manrique E; Sänger N; Fiegel H; Ochsendorf F; Klingebiel T; Bader P; Jarisch A
    Ann Hematol; 2021 Nov; 100(11):2831-2841. PubMed ID: 34536088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular adrenal rest tumor screening and fertility counseling among males with congenital adrenal hyperplasia.
    Chaudhari M; Johnson EK; DaJusta D; Nahata L
    J Pediatr Urol; 2018 Apr; 14(2):155.e1-155.e6. PubMed ID: 29330018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for fertility preservation in pediatric and adolescent girls with planned gonadotoxic treatment.
    Mgboji GE; Cordeiro Mitchell CN; Bedrick BS; Vaidya D; Tao X; Liu Y; Maher JY; Christianson MS
    J Assist Reprod Genet; 2021 Oct; 38(10):2713-2721. PubMed ID: 34370210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature.
    Adank MC; van Dorp W; Smit M; van Casteren NJ; Laven JS; Pieters R; van den Heuvel-Eibrink MM
    Fertil Steril; 2014 Jul; 102(1):199-205.e1. PubMed ID: 24780076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of fertility preservation in adolescents with Klinefelter syndrome.
    Rives N; Milazzo JP; Perdrix A; Castanet M; Joly-Hélas G; Sibert L; Bironneau A; Way A; Macé B
    Hum Reprod; 2013 Jun; 28(6):1468-79. PubMed ID: 23539613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental influences on sperm banking attempts among adolescent males newly diagnosed with cancer.
    Klosky JL; Flynn JS; Lehmann V; Russell KM; Wang F; Hardin RN; Eddinger JR; Zhang H; Schenck LA; Schover LR
    Fertil Steril; 2017 Dec; 108(6):1043-1049. PubMed ID: 29202957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy.
    Sen M; Kurl A; Khosroshahi A
    Lupus; 2021 Aug; 30(9):1509-1514. PubMed ID: 34053364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility counseling and preservation discussions for females with Turner syndrome in pediatric centers: practice patterns and predictors.
    Morgan TL; Kapa HM; Crerand CE; Kremen J; Tishelman A; Davis S; Nahata L
    Fertil Steril; 2019 Oct; 112(4):740-748. PubMed ID: 31272723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients.
    Marder W; McCune WJ; Wang L; Wing JJ; Fisseha S; McConnell DS; Christman GM; Somers EC
    Gynecol Endocrinol; 2012 Aug; 28(8):624-7. PubMed ID: 22296584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum tolerable dose of cyclophosphamide and azathioprine in Pakistani patients with primary renal disease.
    Ali SS; Rabbani MA; Moinuddin SS; Virani S; Farooque F; Salam A; Ahmad A
    J Pak Med Assoc; 2004 Jan; 54(1):39-42. PubMed ID: 15058645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network.
    Henes M; Henes JC; Neunhoeffer E; Von Wolff M; Schmalzing M; Kötter I; Lawrenz B
    Lupus; 2012 Aug; 21(9):953-8. PubMed ID: 22438026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility Preservation Counseling for Pediatric and Adolescent Cancer Patients.
    Campbell JE; Assanasen C; Robinson RD; Knudtson JF
    J Adolesc Young Adult Oncol; 2016 Mar; 5(1):58-63. PubMed ID: 26812454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
    Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
    Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive.
    Baysal Ö; Bastings L; Beerendonk CC; Postma SA; IntHout J; Verhaak CM; Braat DD; Nelen WL
    Hum Reprod; 2015 Jul; 30(7):1625-34. PubMed ID: 26034191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.